Menu
Back to Journals » Orthopedic Research and Reviews » Volume 4
Rationale, characteristics, and clinical performance of the OsteoSponge®: a novel allograft for treatment of osseous defects
Authors Miller L, Jacofsky, Kirker K, Fitzpatrick, Juda, Block J
Received 22 December 2011
Accepted for publication 2 March 2012
Published 3 April 2012 Volume 2012:4 Pages 9—17
DOI https://doi.org/10.2147/ORR.S29397
Review by Single anonymous peer review
Peer reviewer comments 5
Larry E Miller1,2, David J Jacofsky3, Kelly R Kirker4, Kristin L Fitzpatrick5, Gregory A Juda6, Jon E Block2
1Miller Scientific Consulting, Arden, NC, USA; 2Jon Block Group, San Francisco, CA, USA; 3CORE Institute, Phoenix, AZ, USA; 4Center for Biofilm Engineering, Bozeman, MT, USA; 5Department of Biological Structure, University of Washington, Seattle, WA, USA; 6Bacterin International, Belgrade, MT, USA
Abstract: A variety of bone grafts and bone graft substitutes, each with distinctly different characteristics, is available to the orthopedic surgeon for various reconstructive procedures. However, adequate reconstruction of osseous defects remains a therapeutic challenge. Each bone graft option has a unique set of benefits and risks that must be considered in relation to the particular pathology, and to patient characteristics and comorbidities, in order to achieve the best possible outcome. The OsteoSponge® allograft consists of 100% demineralized human cancellous bone, with no additional carrier materials. The OsteoSponge is compressible, allowing precise graft placement in most osseous defects; subsequent expansion completely fills the void. The material is prepared using methods that preserve native growth factors, thereby promoting cellular ingrowth, proliferation, and ultimately osteogenesis. Preliminary evidence suggests that the OsteoSponge matrix is safe and effective when used in surgical treatment of osseous defects. This article describes the rationale for, and characteristics of, the OsteoSponge, and summarizes the results from preclinical and human studies.
Keywords: allograft, bone graft, demineralized bone, osseous defect, OsteoSponge
© 2012 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.